Literature DB >> 1703781

Reactivity of cloned, expressed human Fc gamma RIII isoforms with monoclonal antibodies which distinguish cell-type-specific and allelic forms of Fc gamma RIII.

M L Trounstine1, G A Peltz, H Yssel, T W Huizinga, A E von dem Borne, H Spits, K W Moore.   

Abstract

We have isolated and expressed a cDNA encoding human NK cell Fc gamma RIII. The NK cell cDNA differs from the neutrophil Fc gamma RIII cDNA by a number of point mutations and encodes an additional 21 amino acids at its C-terminus. When transiently expressed neutrophil and NK cell Fc gamma RIII were digested with N-glycanase, deglycosylated neutrophil Fc gamma RIII had a more rapid electrophoretic mobility than NK cell Fc gamma RIII, as is observed for the human Fc gamma RIII isoforms on normal cells. The neutrophil and NK cell Fc gamma RIII isoforms apparently result from cell-type specific expression of different forms of Fc gamma RIII mRNA. A TaqI RFLP was also found for human Fc gamma RIII. Monoclonal antibodies which have been used to distinguish the neutrophil and NK cell Fc gamma RIII isoforms and the NA1 and NA2 alleles of human neutrophil Fc gamma RIII were employed to study the expression of two Fc gamma RIII cDNA clones derived from neutrophils and NK cells. Fc gamma RIII encoded by the neutrophil-derived cDNA reacts with the monoclonal antibody CLBgran11, while the NK-cell Fc gamma RIII cDNA expresses the Fc receptor which carries an antigenic determinant recognized by the antibody GRM1. Characterization of hybrid Fc gamma RIII constructed by interchange of restriction fragments between the neutrophil and NK cell cDNAs allowed localization of antigenic determinants recognized by the monoclonal antibodies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1703781     DOI: 10.1093/intimm/2.4.303

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  6 in total

1.  A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease.

Authors:  J Wu; J C Edberg; P B Redecha; V Bansal; P M Guyre; K Coleman; J E Salmon; R P Kimberly
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Functional expression in mast cells of chimeric receptors with antibody specificity.

Authors:  N L Bach; T Waks; D G Schindler; Z Eshhar
Journal:  Cell Biophys       Date:  1994

3.  Soluble Fc gamma receptor III in human plasma originates from release by neutrophils.

Authors:  T W Huizinga; M de Haas; M Kleijer; J H Nuijens; D Roos; A E von dem Borne
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

Review 4.  Using guinea pigs in studies relevant to asthma and COPD.

Authors:  Brendan J Canning; Yangling Chou
Journal:  Pulm Pharmacol Ther       Date:  2008-02-02       Impact factor: 3.410

5.  Natural Killer (NK) cell deficiency associated with an epitope-deficient Fc receptor type IIIA (CD16-II).

Authors:  S Jawahar; C Moody; M Chan; R Finberg; R Geha; T Chatila
Journal:  Clin Exp Immunol       Date:  1996-03       Impact factor: 4.330

6.  Fcγ receptor IIIb (CD16b) polymorphisms are associated with susceptibility to idiopathic pulmonary fibrosis.

Authors:  Stylianos Bournazos; Irini Bournazou; John T Murchison; William A Wallace; Pauline McFarlane; Nikhil Hirani; A John Simpson; Ian Dransfield; Simon P Hart
Journal:  Lung       Date:  2010-10-06       Impact factor: 2.584

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.